ArticleCureus2021

A Comparative Study of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes of Polish Therapeutic Program in Non-Tertiary Institution.

Tomasz Skrzypczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.